SPRINT-MS/NN 102 phase II trial of ibudilast in progressive MS: Baseline characteristics

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2015
This article has no abstract
Epistemonikos ID: c15d775488e8edc9c7bd1b5bcdbdd7bcd8e55735
First added on: Apr 30, 2026